CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...
Phase 3
Rochester, Minnesota, United States and 253 other locations
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Rochester, Minnesota, United States and 73 other locations
first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-1-23 in patients with advanced cancer...
Phase 1
Rochester, Minnesota, United States and 13 other locations
-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...
Phase 1
Rochester, Minnesota, United States and 123 other locations
can be given alone or with cemiplimab to patients with ovarian cancer or cancer of the uterus* The study will also look at the leve...
Phase 1, Phase 2
Rochester, Minnesota, United States and 55 other locations
A Study of Emi-Le in Participants with Solid Tumors
Phase 1, Phase 2
Rochester, Minnesota, United States and 25 other locations
This is a Phase 1/2, open-label, multicenter study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics and anti-tumor activity of...
Phase 1, Phase 2
Rochester, Minnesota, United States and 19 other locations
This is a two-part, open-label, multicenter, dose escalation and dose expansion study designed to evaluate the safety, tolerability, pharmacokinetics...
Phase 1, Phase 2
Rochester, Minnesota, United States and 13 other locations
This clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors. The main goals of this study are to...
Phase 1, Phase 2
Rochester, Minnesota, United States and 82 other locations
The proposed study design is a single arm Phase II trial to document the feasibility of carboplatin-mirvetuximab - in patients with advanced-stage EO...
Phase 2
Rochester, Minnesota, United States and 8 other locations
Clinical trials
Research sites
Resources
Legal